Because Doing “It” Matters to Patients: Development and Evaluation of a What Matters to Me Tool That Elicits Patients' Priorities to Support Cancer Treatment Shared Decision-Making

IF 3.1 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2025-09-11 DOI:10.1002/cam4.71169
Bruce D. Rapkin, Ariana E. Tao, Brieyona C. Reaves, Krystal A. Rivera, Lauren K. Jones, Rita R. Ravichandar, Dennis Yi-Shin Kuo, Rafi Kabarriti, Alexander I. Sankin, Ahmed A. Aboumohamed, Kara L. Watts, Damara N. Gutnick, Ellen Miller-Sonet
{"title":"Because Doing “It” Matters to Patients: Development and Evaluation of a What Matters to Me Tool That Elicits Patients' Priorities to Support Cancer Treatment Shared Decision-Making","authors":"Bruce D. Rapkin,&nbsp;Ariana E. Tao,&nbsp;Brieyona C. Reaves,&nbsp;Krystal A. Rivera,&nbsp;Lauren K. Jones,&nbsp;Rita R. Ravichandar,&nbsp;Dennis Yi-Shin Kuo,&nbsp;Rafi Kabarriti,&nbsp;Alexander I. Sankin,&nbsp;Ahmed A. Aboumohamed,&nbsp;Kara L. Watts,&nbsp;Damara N. Gutnick,&nbsp;Ellen Miller-Sonet","doi":"10.1002/cam4.71169","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Cancer impinges on nearly every aspect of the lives of patients, survivors, and loved ones. This study presents progress in developing the “What Matters to Me” Worksheet (WMTM-Worksheet), designed to elicit personal priorities across multiple life domains. WMTM-Worksheet items were finalized based on clinician recommendations and patient feedback. Individuals at any point in cancer treatment were interviewed post-appointment about using the WMTM-Worksheet prior to their appointment.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>To finalize the WMTM Worksheet, initial samples of clinicians and patients were interviewed on its content and usability. Oncology clinicians were recruited by email; 25 accepted and were surveyed about current practices of incorporating patient priorities and preferences into treatment planning, and the usability, practicality, and feasibility of the 17-item WMTM Worksheet. Patients were English- or Spanish-speaking adults diagnosed with gynecological, head and neck, or urological cancers. Patients at any point in active treatment or follow-up were eligible. An initial sample of 15 patients was administered a cognitive interview about the WMTM Worksheet by telephone to assess its clarity, relevance, and feasibility. Next, 61 patients taking part in the user experience portion of this study were identified through the electronic medical record (EMR), contacted by telephone, and offered participation in a onetime interview regarding the WMTM Worksheet. They received the WMTM Worksheet prior to a clinic appointment. Questions regarding user experience were administered by telephone 1–3 days later.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 61 patient respondents, 57% were over age 65, 59% female, 41% Hispanic, 45% Black; 49% had an annual income below $35,000. Patient responses yielded seven principal components, reflecting domains such as symptoms, family caregiving, work, and hobbies. Most patients (62%) said the WMTM-Worksheet helped them think about disease and treatment; 30% said it helped communication with clinicians. Eighty-five percent were glad to share their concerns, and only 10% found it difficult to complete.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The WMTM-Worksheet can bring patients' broader priorities into care planning. Patients may be better able to anticipate and avoid problems. Discussion of priorities validates patients' concerns and promotes trust. Implementation will require the clinical infrastructure to support shared decision-making and incorporate the WMTM-Worksheet into workflow. Oncologists may benefit from communications training to determine patients' concerns and present options that best address their priorities.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 17","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71169","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71169","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Cancer impinges on nearly every aspect of the lives of patients, survivors, and loved ones. This study presents progress in developing the “What Matters to Me” Worksheet (WMTM-Worksheet), designed to elicit personal priorities across multiple life domains. WMTM-Worksheet items were finalized based on clinician recommendations and patient feedback. Individuals at any point in cancer treatment were interviewed post-appointment about using the WMTM-Worksheet prior to their appointment.

Methods

To finalize the WMTM Worksheet, initial samples of clinicians and patients were interviewed on its content and usability. Oncology clinicians were recruited by email; 25 accepted and were surveyed about current practices of incorporating patient priorities and preferences into treatment planning, and the usability, practicality, and feasibility of the 17-item WMTM Worksheet. Patients were English- or Spanish-speaking adults diagnosed with gynecological, head and neck, or urological cancers. Patients at any point in active treatment or follow-up were eligible. An initial sample of 15 patients was administered a cognitive interview about the WMTM Worksheet by telephone to assess its clarity, relevance, and feasibility. Next, 61 patients taking part in the user experience portion of this study were identified through the electronic medical record (EMR), contacted by telephone, and offered participation in a onetime interview regarding the WMTM Worksheet. They received the WMTM Worksheet prior to a clinic appointment. Questions regarding user experience were administered by telephone 1–3 days later.

Results

Of the 61 patient respondents, 57% were over age 65, 59% female, 41% Hispanic, 45% Black; 49% had an annual income below $35,000. Patient responses yielded seven principal components, reflecting domains such as symptoms, family caregiving, work, and hobbies. Most patients (62%) said the WMTM-Worksheet helped them think about disease and treatment; 30% said it helped communication with clinicians. Eighty-five percent were glad to share their concerns, and only 10% found it difficult to complete.

Conclusion

The WMTM-Worksheet can bring patients' broader priorities into care planning. Patients may be better able to anticipate and avoid problems. Discussion of priorities validates patients' concerns and promotes trust. Implementation will require the clinical infrastructure to support shared decision-making and incorporate the WMTM-Worksheet into workflow. Oncologists may benefit from communications training to determine patients' concerns and present options that best address their priorities.

Abstract Image

因为做“它”对病人很重要:一个对我重要的工具的开发和评估,它可以引出病人的优先事项,以支持癌症治疗的共同决策。
简介:癌症几乎影响着患者、幸存者和亲人生活的方方面面。本研究展示了“什么对我重要”工作表(wmtm -工作表)的发展进展,旨在引出个人在多个生活领域的优先事项。wmtm -工作表项目根据临床医生建议和患者反馈最终确定。在癌症治疗的任何阶段,患者在预约后接受了关于在预约前使用wmtm -工作表的访谈。方法:为完善WMTM工作表,对临床医生和患者的初始样本进行了内容和可用性访谈。通过电子邮件招募肿瘤临床医生;25人接受并接受调查,了解将患者优先级和偏好纳入治疗计划的当前做法,以及17项WMTM工作表的可用性、实用性和可行性。患者是说英语或西班牙语的成年人,被诊断患有妇科、头颈部或泌尿系统癌症。接受积极治疗或随访的患者均符合条件。对15名患者的初始样本通过电话进行了关于WMTM工作表的认知访谈,以评估其清晰度、相关性和可行性。接下来,61名参与本研究用户体验部分的患者通过电子病历(EMR)被识别出来,通过电话联系,并被邀请参加关于WMTM工作表的一次性访谈。他们在门诊预约前收到了WMTM工作表。关于用户体验的问题在1-3天后通过电话进行管理。结果:在61例应答患者中,57%年龄在65岁以上,59%为女性,41%为西班牙裔,45%为黑人;49%的人年收入低于3.5万美元。患者的反应产生了七个主要组成部分,反映了症状、家庭护理、工作和爱好等领域。大多数患者(62%)表示,wmtm工作表帮助他们思考疾病和治疗;30%的人说这有助于与临床医生沟通。85%的人很高兴分享他们的担忧,只有10%的人觉得很难完成。结论:WMTM-Worksheet可以将患者更广泛的优先事项纳入护理计划。患者可以更好地预测和避免问题。对优先事项的讨论验证了患者的担忧并促进了信任。实施将需要临床基础设施支持共享决策,并将wmtm工作表纳入工作流程。肿瘤学家可能会从沟通培训中受益,以确定患者的关注点,并提出最能解决他们优先问题的方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信